Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended March 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Ltd has submitted to BSE a compliance certificate from its Registrar and Share Transfer Agent (RTA), Satellite Corporate Services Pvt. Ltd., as required under SEBI Regulation 74(5) for the quarter ended March 31, 2025. The certificate confirms that any physical share certificates received for dematerialization of equity shares have been listed, verified, mutilated, and the depository's name has been recorded as the registered owner. Importantly, the RTA noted that no physical certificates were received from Genpharmasec shareholders for dematerialization during this quarter. The filing was signed by Mr. Sohan Chaturvedi, Whole-time Director and CFO.
This is a routine regulatory compliance filing with no material impact on the company's operations, financials, or shareholders. No physical shares were dematerialized during the quarter, indicating that essentially all shares may already be in demat form.